EyePoint Pharmaceuticals
EYPT
EYPT
66 hedge funds and large institutions have $85.6M invested in EyePoint Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 16 closing their positions.
Holders
66
Holders Change
-8
Holders Change %
-10.81%
% of All Funds
1.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
19
Reduced
19
Closed
16
Calls
$213K
Puts
$36K
Net Calls
+$177K
Net Calls Change
-$27K
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$2.7M |
2 |
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
|
$662K |
3 |
3
Squarepoint
New York
|
$193K |
4 |
4
Morgan Stanley
New York
|
$263K |
5 |
5
Renaissance Technologies
New York
|
$210K |